In this study, the potential prognostic value of serial ultrasonographic, endocrinological and biochemical measurements in the early pregnancy of women with a history of unexplained recurrent miscarriage was examined. A total of 113 pregnancies among 93 women were studied, of which 77 (68%) resulted in live birth, whereas 36 (32%) ended in a miscarriage. The normal range (5-95th centile) of various measurements was derived from pregnancies which resulted in a live birth. Among the 36 failed pregnancies, 42% had one or more human chorionic gonadotrophin (HCG) measurements, 35% had one or more gestation-sac diameter measurements, 33% had one or more embryonic heart rate measurements, 20% had one or more crown-rump length measurements and 9% had one or more placental protein 14 measurements below the normal range, a week or more prior to the confirmation of miscarriage. Altogether, 22/36 ⍧ 61% of the failed pregnancies could have been predicted on the basis of one or more of the measurements below the normal range.
Introduction
Recurrent miscarriage, defined as three or more consecutive pregnancy losses before the completion of the 28th week (Crosignani and Rubin, 1991) , occurs in 0.5-1.0% of the population. In a significant proportion of cases, the underlying cause of the recurrent problem is still unknown, even after detailed investigations (Stephenson, 1996) .
Women with unexplained recurrent miscarriage very often experience a high level of anxiety when they conceive again. They welcome reassurance and regular monitoring, including pelvic ultrasonography, which together are the cornerstone of 'tender loving care', perceived as one of the most important factors in improving the outcome in this group of women (Stray Pedersen and Stray Pedersen, 1984; Liddell et al., 1991; Clifford et al., 1997) .
Overall, about 30% of women with unexplained recurrent miscarriage will miscarry again in a subsequent pregnancy (Quenby and Farquharson, 1993, Clifford et al., 1997) . Several factors have been identified to be associated with a poor prognosis: menstrual irregularity, maternal age of ജ40 years, six or more previous losses, and lack of supportive care (Quenby and Farquharson, 1993, Clifford et al., 1997) . However, very little, if anything, is known of the potential prognostic value of the ultrasonographic, endocrinological and biochemical measurements in the early pregnancy of women with a history of unexplained recurrent miscarriage.
In this retrospective study, our aims were: (i) to compare the serial ultrasonographic, endocrinological (human chorionic gonadotrophin, HCG) and biochemical (placental protein 14, PP14) measurements between pregnancies with and without successful outcomes, in a group of women with unexplained recurrent miscarriage; and (ii) to establish the predictive value, if any, of these measurements in the outcome of the pregnancies.
Materials and methods

Subjects
All women included in this study attended the Recurrent Miscarriage Clinic at the Jessop Hospital for Women, Sheffield. They all had a history of three or more consecutive miscarriages. The women underwent investigations according to the local clinical protocol (Li, 1998) , following which no obvious, definite cause was identified for their recurrent miscarriage. The chromosomal analyses of both partners were normal; lupus anticoagulant and anticardiolipid antibodies were negative; thyroid function was normal; the plasma luteinizing hormone on day 5 of the cycle was ഛ10 IU/l; there was no ultrasonographic evidence of polycystic ovaries or uterine pathology; and hysterosalpingography showed a normal uterine cavity.
Immediately after the women had conceived, they attended the Recurrent Miscarriage Clinic at weekly or, in some cases, fortnightly intervals, for pelvic ultrasonography and blood sampling for HCG and PP14 measurements, until 12 weeks gestation. There was no therapeutic intervention, other than tender loving care, in all these pregnancies.
In all, there were 113 pregnancies investigated from 93 women over a 4-year period, from 1993 to 1996. All these pregnancies had ultrasonographic evidence of viable pregnancy, i.e. demonstrable fetal heart beats on at least one occasion during the index pregnancy.
Ultrasonography
All the ultrasonographic measurements were made by a single, qualified ultrasonographer (C.B.). Early ultrasound scans were performed using a Toshiba Tosbee 240A scanner with a 6-MHz transvaginal array transducer, and later (from 9-10 weeks gestation) scans were performed using a 3.5-MHz transabdominal curvilinear array transducer. The measurements taken were: embryo crown-rump length, mean gestation-sac size (Bromley et al., 1991) , yolk-sac size (Lindsay et al., 1992) , amnion diameter (Horrow, 1992) , embryonic heart rate and trophoblast thickness. The mean number of scans per patient for each pregnancy was four.
Blood sample measurements A 10-ml blood sample was taken at each clinic visit. Part of the serum sample was sent for HCG measurement, and the remainder was stored at -20°C for subsequent PP14 measurement.
Serum total HCG concentrations were measured in all 113 pregnancies; the number of samples per pregnancy ranged from 1-10 (mean ϭ 4). The HCG assay was performed using the Abbott Axsym analyser (Abbott Diagnostics, Maidenhead, Berks, UK) at the Department of Clinical Chemistry, Royal Hallamshire Hospital. This is an automated micro-particle enzyme immunoassay using an antibody sandwich format mouse monoclonal anti-βHCG-coated particle and goat polyclonal anti-βHCG-alkaline phosphatase conjugate. The substrate used was 4-methylumbelliferyl phosphate. The assay was calibrated against the World Health Organization Third International Standard (75/537) and measured the total βHCG with a sensitivity of 2 IU/l.
PP14 serum concentrations were measured in 68 of the 113 pregnancies; the number of samples per pregnancy varied from 1-8 (mean ϭ 4). PP14 was measured by radioimmunoassay using the method described previously (Bolton et al., 1983) . In brief, PP14 was iodinated by the chloramine-T method and the resulting tracer was purified using a column of Con-A Sepharose. For the assay 100 µl of 1 ng/ml PP14 tracer and 100 µl of standard or sample was incubated at room temperature for 24 h with 100 µl antiserum at a dilution to bind 45% of the added tracer. The antibody-bound tracer was separated from the unbound using Amerlex-MMT magnetic separating reagent (Amersham International, Little Chalfont, Bucks, UK). The sensitivity of the assay was 3 ng/ml and the intra-and inter-assay coefficients of variation were below 10%.
Calculation of gestational age
The calculation of gestational age was based on a 28-day cycle. In women with regular long (Ͼ28 days) cycles prior to conception, the gestational age was adjusted appropriately, on the assumption that ovulation occurred 14 days prior to the onset of the next expected period.
Analysis of data
The data were analysed with the use of the statistical package for social sciences (SPSS-PC). The 5th to 95th percentile of the measurements in women with successful outcome were used to construct the normal ranges. In women who miscarried again, the measurements obtained on or after the day that the miscarriage was diagnosed were excluded from analysis.
Results
Of the 113 pregnancies included in this study, 77 (68%) resulted in a live birth while 36 (32%) ended in a miscarriage. The age of the women who went to term ranged from 21-45 years (median ϭ 31), while those of women who miscarried ranged from 22-44 years (median ϭ 32). There was no difference in the age between the two groups of women (miscarriage and live birth). Figure 1 shows the mean gestation-sac diameter of the fetus during the first trimester of pregnancy. Of the 70 measurements obtained from 31 pregnancies which resulted in miscarriage, 17 (24%) were below the 5th percentile derived from pregnancies which resulted in a live birth. Figure 2 shows the embryonic heart rate measurements. Of the 58 measurements obtained from 21 pregnancies which resulted in a miscarriage, seven (12%) were below the 5th percentile derived from pregnancies which resulted in a live birth. Figure 3 shows the crown-rump length (CRL) measurement of the fetus during the first trimester of pregnancy. Of the 81 measurements obtained from 30 pregnancies which resulted in a miscarriage, nine (11%) were below the 5th percentile derived from pregnancies which resulted in a live birth.
Ultrasonographic measurements
For the remaining ultrasound measurements, i.e. yolk-sac size, amnion diameter and trophoblast thickness, less than 10% of the data in the miscarriage group were below the 5th percentile derived from pregnancies which resulted in a live birth. The difference between CRL and mean gestation-sac diameter did not improve the results achieved by mean gestation-sac diameter alone. Figure 4 shows the concentrations of HCG in the plasma during the first trimester of pregnancy. Of the 107 HCG measurements obtained from 35 pregnancies which resulted in a miscarriage, 31 (29%) were below the 5th percentile for pregnancies which resulted in a live birth. Figure 5 shows the concentrations of PP14 in the plasma during the first trimester of pregnancy. Of the 69 PP14 measurements obtained from 22 pregnancies which resulted in a miscarriage, two (3%) were below the 5th percentile for pregnancies which resulted in a live birth.
HCG measurements
PP14 measurements
Relationship between measurements
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Time sequence
Of the 36 pregnancies which resulted in miscarriage, four (11%) abnormal (below the 5th percentile) HCG measurements were noted 1 week prior to the diagnosis of miscarriage, and 11 (31%) abnormal results were noted 2 or more weeks prior to the diagnosis. Of the 31 pregnancies which resulted in miscarriage, five (16%) abnormal mean sac diameter measurements were noted 1 week prior to the diagnosis of miscarriage, and six (19%) abnormal results were noted 2 or more weeks prior to the diagnosis. Of the 21 pregnancies which resulted in miscarriage, two (9%) abnormal embryonic heart rate measurements were noted 1 week prior to the diagnosis of miscarriage, and five (24%) abnormal results were noted 2 or more weeks prior to the diagnosis. Of the 30 pregnancies which resulted in miscarriage, two (7%) abnormal CRL measurements were noted 1 week prior to the diagnosis of miscarriage, and four (13%) abnormal results were noted 2 or more weeks prior to the diagnosis. Of the 22 pregnancies which resulted in miscarriage, and one (4.5%) abnormal PP14 measurement was noted 1 week prior to the diagnosis of miscarriage, one (4.5%) abnormal result was noted 2 weeks prior to the diagnosis.
Predicting the outcome
Of the 36 pregnancies which subsequently failed, 22 (61%) could be predicted by one or more abnormal endocrinological, or ultrasonographic measurements. βHCG alone would have predicted 17 failed pregnancies, whereas gestation-sac diameter alone would have predicted 11 failed pregnancies. A combination of the two measurements would have predicted 19 failed pregnancies (Table I ). The addition of fetal heart rate measurement predicted two further cases, and PP14 measurement a further case.
Discussion
In this study the possible value of serial βHCG, PP14 and various ultrasonographic measurements, in predicting the pregnancy outcome of women with a history of recurrent pregnancy loss, was examined. Although a number of studies have examined the possible value of ultrasonographic measurements in predicting the outcome (Opsahl and Pettit, 1993; Cunningham et al., 1995; Stampone et al., 1996) , this is the first study which simultaneously examined ultrasonographic, endocrinological and biochemical factors in a group of women with recurrent pregnancy loss. While it is uncertain if the observations obtained in this study could apply to the general population, they should provide useful prognostic information in women with recurrent miscarriage. Earlier work by Fadda et al. (1993) , Johnson et al. (1993) , Cunningham et al. (1995) and recently by Dickey et al. (1997) suggested that the CRL was a useful indicator of embryonic demise. Our own work confirms that, in a recurrent miscarriage group, CRL is able to distinguish those patients that subsequently have a successful pregnancy and those whose pregnancy fails. The mean sac size (MSS) was also found to be a useful discriminatory parameter in determining pregnancy outcome in the early weeks in a recurrent miscarriage group (Opsahl and Pettit, 1993; Cunningham et al., 1995) . However, 3528 in this study the difference between the two measurements (MSS minus CRL) was not an effective means of separating the miscarriage group from the successful group, in contrast to the findings of Bromley et al. (1991) that MSS -CRL Ͻ5 mm was associated with a significantly higher proportion of failed pregnancies compared with that of MSS -CRL Ͼ5mm. It was therefore concluded that the CRL and the mean sac diameter are important parameters to monitor in early pregnancy, in a recurrent miscarriage group. Lindsay et al. (1992) and Stampone et al. (1996) suggested that measurement of the yolk sac was a good indicator of early fetal demise but this was not confirmed in this study. Horrow (1992) suggested that an enlarged amniotic cavity compared with the CRL was a predictor of early embryonic demise, but the data in this study did not show that the maximum amniotic sac diameter was a useful parameter. In measurement of the trophoblast thickness, the thickest part of the trophoblast was selected to assess placentation in early pregnancy. The results of this study showed that this was not effective in predicting embryo demise. A quick placental measurement in this way is possible in the recurrent miscarriage clinic, but the effect of the placenta on fetal growth is complex, as discussed by Harris and Barth (1993) . A more in-depth study of placental structure and function is therefore necessary. Finally, M-mode measurements of the embryonic heart were also undertaken: the results showed that pregnancies which failed showed a tendency towards bradycardia, as reported by Ikegawa (1995) . In conclusion, the work was in agreement with that of Burwinkel et al. (1993) which indicated that a single ultrasound scan, taking the measurements of CRL, mean sac diameter and fetal heart rate, could predict whether a pregnancy in a recurrent miscarriage group would be successful or not.
In women without a history of recurrent miscarriage, the finding of fetal heart beats in the first trimester by transvaginal ultrasonography has been considered to be a reassuring sign for an ongoing pregnancy, with a spontaneous miscarriage rate of Ͻ5% (Achiron et al., 1991; Nazari et al., 1991) . However, in women over 35 years of age, the documentation of cardiac activity is not necessarily a reassuring sign, with a miscarriage rate of 10% in women 36-39 years and 29% in women ജ40 years of age (Deaton et al., 1997) . In the series of women in this study with unexplained recurrent miscarriage, the documentation of cardiac activity is followed by subsequent miscarriage in 32% of cases, consequently, we suggest that undue optimism should not be conveyed to patients with a history of recurrent miscarriage, even if fetal heart beats are demonstrable on transvaginal ultrasonography. Tulppala et al. (1995) reported that the serum concentrations of PP14 in the luteal phase of women with recurrent miscarriage are lower than those of normal controls. However, the predictive value of PP14, measured in early pregnancy, has not been examined previously. Arthur et al. (1995) reported that pregnancy may progress normally despite low serum PP14 concentrations, which suggests indirectly that PP14 is not vital in the maintenance of pregnancy. In this study, it was found that serial PP14 measurements in early pregnancy did not discriminate between pregnancies which would fail or succeed.
In contrast, serial βHCG measurements, in early pregnancy, appear to be of value in predicting pregnancy outcome. It was found that 42% of pregnancies which miscarried in the first trimester were associated with low βHCG concentrations, prior to the diagnosis of miscarriage. Moreover, the time sequence analysis showed that abnormal concentrations were evident 2 or more weeks prior to the miscarriage in 31% of pregnancies which subsequently miscarried. It appears that serial βHCG measurement in early pregnancy is the best prognostic indicator of pregnancy outcome, amongst all the measurements examined in this study. In a recent smaller study involving women with recurrent miscarriage, France et al. (1996) found that, among seven pregnancies which miscarried but earlier had evidence on ultrasound of an active fetal heart, HCG levels in the first 9 weeks were consistently below the 10th percentile for 30 singleton pregnancies which progressed successfully to term. The authors also concluded that subnormal HCG concentrations were a useful predictor of outcome. There is some controversy as to how sensitive βHCG measurement is in discriminating pregnancy outcome. Whittaker et al. (1989) found that seven out of eight early pregnancy failures had normal HCG concentrations prior to 8 weeks gestation, but France et al. (1996) found that, in all seven pregnancies which miscarried, the HCG levels were consistently low in the first 9 weeks of pregnancy. Our own observation suggests that miscarriage in the first trimester may be subdivided into two groups: those associated with a low βHCG level (~40%) prior to miscarriage and those associated with normal levels (~60%). It is possible that different mechanisms are involved in these two types of miscarriage, and further studies are required to further address this issue. An interesting correlation between serum βHCG concentration and fetal heart rates during the first trimester of pregnancy was reported by Rotsztejn et al. (1993) . The authors speculated that the βHCG molecule has a regulatory effect on fetal heart rates.
To conclude, it has been found that endocrinological, biochemical and ultrasonographic measurements in early pregnancy are useful in predicting the outcome in a group of women with unexplained recurrent miscarriage. Abnormal results may be evident 2 or more weeks prior to the diagnosis of miscarriage. Among the various measurements examined, the two most useful are βHCG and gestation-sac diameter. CRL and fetal heart rate measurements are of possible value, but the remaining measurements, including PP14, are of little value. Our observation also suggests that serial endocrinological and ultrasonographic measurements may give insight into the different mechanisms of early pregnancy loss.
